Clinical Trial Alert

Blog Post

Clinical Trial Alert: Phase 2 Pivotal Study of Sevasemten (EDG-5506) in Adults with Becker Muscular Dystrophy

By Sujatha Gurunathan | June 17, 2024
Blog Post

Clinical Study Alert: Open-Label, Observational Study of Risdiplam in Adults with SMA

By Sujatha Gurunathan | May 17, 2024
Blog Post

Clinical Trial Alert: Phase 3 Study of ALXN1720 in Adults with Generalized Myasthenia Gravis (gMG)

By Sujatha Gurunathan | May 13, 2024
Blog Post

Clinical Study Alert: Phase 2 Study of Vamorolone in Adults with BMD

By Sujatha Gurunathan | April 2, 2024
Blog Post

Clinical Study Alert: Phase 2 Study of Brogidirsen in Boys with DMD

By Sujatha Gurunathan | March 29, 2024
Blog Post

Clinical Study Alert: A Phase 1/2 Study of Safety and Efficacy of LX2006 Gene Therapy in Adults with Cardiomyopathy Associated with Friedreich Ataxia

By Sujatha Gurunathan | March 25, 2024
Blog Post

Clinical Trial Alert: Medical Device Feasibility Study for People with ALS

By MDA Staff | December 21, 2023
Mitochondrion in cell cross section
Blog Post

Simply Stated: Research Updates in Leigh Syndrome

By Sujatha Gurunathan | December 6, 2023
Blog Post

Clinical Trial Alert: Phase 3 Study of Brepocitinib in Adults with Dermatomyositis

By Sujatha Gurunathan | November 16, 2023
Blog Post

Clinical Trial Alert: Phase 2/3 Study of an Investigational Medication in Pediatric Patients with Generalized Myasthenia Gravis

By Sujatha Gurunathan | October 4, 2023